Fennec Pharmaceuticals Inc (FENC)
4.72
+0.08
(+1.72%)
USD |
NASDAQ |
Nov 21, 16:00
4.72
0.00 (0.00%)
After-Hours: 20:00
Fennec Pharmaceuticals Shareholders Equity (Quarterly): -5.171M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | -5.171M |
June 30, 2024 | -1.357M |
March 31, 2024 | 3.014M |
December 31, 2023 | -11.62M |
September 30, 2023 | -10.53M |
June 30, 2023 | -9.727M |
March 31, 2023 | -7.339M |
December 31, 2022 | -2.569M |
September 30, 2022 | 2.802M |
June 30, 2022 | 8.541M |
March 31, 2022 | 12.52M |
December 31, 2021 | 15.77M |
September 30, 2021 | 19.01M |
June 30, 2021 | 22.28M |
March 31, 2021 | 24.93M |
December 31, 2020 | 29.07M |
September 30, 2020 | 31.18M |
June 30, 2020 | 36.13M |
March 31, 2020 | 8.461M |
December 31, 2019 | 11.88M |
September 30, 2019 | 15.00M |
June 30, 2019 | 16.48M |
March 31, 2019 | 19.21M |
December 31, 2018 | 21.31M |
September 30, 2018 | 22.86M |
Date | Value |
---|---|
June 30, 2018 | 24.86M |
March 31, 2018 | 25.66M |
December 31, 2017 | 26.76M |
September 30, 2017 | 8.858M |
June 30, 2017 | 9.679M |
March 31, 2017 | 2.861M |
December 31, 2016 | 3.57M |
September 30, 2016 | 4.22M |
June 30, 2016 | 4.653M |
March 31, 2016 | 0.243M |
December 31, 2015 | 0.548M |
September 30, 2015 | 1.019M |
June 30, 2015 | 1.112M |
March 31, 2015 | 0.826M |
December 31, 2014 | 0.613M |
September 30, 2014 | -3.228M |
June 30, 2014 | -4.658M |
March 31, 2014 | -4.334M |
December 31, 2013 | -1.455M |
September 30, 2013 | -4.127M |
June 30, 2013 | -2.429M |
March 31, 2013 | -9.065M |
December 31, 2012 | -4.957M |
September 30, 2012 | 1.284M |
June 30, 2012 | 2.045M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-11.62M
Minimum
Dec 2023
36.13M
Maximum
Jun 2020
8.864M
Average
8.501M
Median
Shareholders Equity (Quarterly) Benchmarks
NovaBay Pharmaceuticals Inc | 1.072M |
Palatin Technologies Inc | -7.686M |
iBio Inc | 17.75M |
Theriva Biologics Inc | 24.64M |
Oragenics Inc | 3.078M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 58.92M |
Total Liabilities (Quarterly) | 64.09M |
Debt to Equity Ratio | -6.207 |
Current Ratio | 7.796 |
Net Debt Paydown Yield | -0.98% |